Should evidence-based proof of drug efficacy be extrapolated to a "class of agents"?

被引:25
作者
Furberg, CD
Psaty, BM
机构
[1] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
[2] Univ Washington, Dept Med Epidemiol & Hlth Sci, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA
关键词
DISEASE; TRIAL;
D O I
10.1161/01.CIR.0000090572.51900.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2608 / 2610
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 2002, National Institute for Health Care Management, P13
[2]  
BALL SG, 1993, LANCET, V342, P821
[3]  
Fox KM, 2003, LANCET, V362, P782
[4]   Are drugs within a class interchangeable? [J].
Furberg, CD ;
Herrington, DM ;
Psaty, BM .
LANCET, 1999, 354 (9185) :1202-1204
[5]   Are all angiotensin-converting enzyme inhibitors interchangeable? [J].
Furberg, CD ;
Pitt, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1456-1460
[6]   Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure [J].
Luzier, AB ;
Forrest, A ;
Adelman, M ;
Hawari, FI ;
Schentag, JJ ;
Izzo, JL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :465-469
[7]   Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency [J].
Maschio, G ;
Alberti, D ;
Janin, G ;
Locatelli, F ;
Mann, JFE ;
Motolese, M ;
Ponticelli, C ;
Ritz, E ;
Zucchelli, P ;
Marai, P ;
Marcelli, D ;
Tentori, F ;
Andriani, M ;
Drago, G ;
Meneghel, G ;
Oldrizzi, L ;
Rugiu, C ;
Salvadeo, A ;
Villa, G ;
Picardi, L ;
Borghi, M ;
Moriggi, M ;
Vendramin, G ;
Fusaroli, M ;
Esposti, ED ;
Fabbri, A ;
Koch, KM ;
Frey, U ;
Schaeffer, J ;
Mann, J ;
Schweitzer, C ;
Zuccala, A ;
Gaggi, R ;
Stahl, R ;
Blaser, C ;
Rivolta, E ;
Buccianti, G ;
Gastaldi, L ;
Baratelli, M ;
Ducret, F ;
Pointet, P ;
Sterzel, R ;
Oberdorf, E ;
Pedrini, L ;
Faranna, P ;
Cairo, G ;
Ferrari, L ;
Albertazzi, A ;
Cappelli, P ;
Cantu, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :939-945
[8]   The QUinapril Ischemic Event Trial (OUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function [J].
Pitt, B ;
O'Neill, B ;
Feldman, R ;
Ferrari, R ;
Schwartz, L ;
Mudra, H ;
Bass, T ;
Pepine, C ;
Texter, M ;
Haber, H ;
Uprichard, A ;
Cashin-Hemphill, L ;
Lees, RS .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (09) :1058-1063
[9]  
PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556, DOI 10.1016/S0140-6736(01)06178-5
[10]  
Yusuf S, 2000, NEW ENGL J MED, V342, P145